{"news_desk": "National", "print_page": "22", "section_name": "Health", "subsection_name": null, "byline": {"original": "By DONALD G. McNEIL Jr", "person": [{"middlename": "G.", "firstname": "Donald", "lastname": "McNEIL", "rank": 1, "role": "reported", "qualifier": "Jr", "organization": ""}]}, "abstract": "Study published by Kaiser Permanente, San Francisco's largest private health insurer, in journal Clinical Infectious Diseases finds that not one of 657 clients given pre-exposure prophylaxis became infected with HIV over period of more than two years; subjects were given two-drug combination called Truvada; findings contradict concerns of critics, who said PrEP could lead to more HIV infections.", "type_of_material": "News", "word_count": "738", "lead_paragraph": "The finding contradicts critics&#8217; predictions that pre-exposure prophylaxis, or PrEP, would lead to less condom use and more H.I.V. infections.", "pub_date": "2015-09-03T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Insurer Says Clients on Daily Pill Have Stayed H.I.V.-Free", "print_headline": "Insurer Says Clients on a Daily Pill Have Stayed Free of H.I.V. for Two Years"}, "snippet": "The finding contradicts critics&#8217; predictions that pre-exposure prophylaxis, or PrEP, would lead to less condom use and more H.I.V. infections.", "multimedia": [{"height": 126, "url": "images/2015/09/03/science/03hiv/03hiv-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/09/03/science/03hiv/03hiv-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/09/03/science/03hiv/03hiv-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/09/03/science/03hiv/03hiv-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/09/03/science/03hiv/03hiv-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/09/03/science/03hiv/03hiv-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/09/03/health/insurer-says-clients-on-daily-pill-have-stayed-hiv-free.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Acquired Immune Deficiency Syndrome", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Kaiser Permanente", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Clinical Infectious Diseases (Journal)", "name": "organizations"}, {"rank": "4", "is_major": "Y", "value": "Truvada (Drug)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Sexually Transmitted Diseases", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "San Francisco (Calif)", "name": "glocations"}, {"rank": "7", "is_major": "N", "value": "Homosexuality and Bisexuality", "name": "subject"}, {"rank": "8", "is_major": "N", "value": "Condoms", "name": "subject"}, {"rank": "9", "is_major": "N", "value": "Volk, Jonathan E", "name": "persons"}], "blog": [], "_id": "55e7708938f0d80b7eeea5fc", "source": "The New York Times"}